ABCL Abcellera Biologics Inc

held by 1 manager in Q2 2022

Manager	% of their portfolio	Held	Activity	Value	Shares
Stanley Druckenmiller Duquesne Family Office	0.51%	1.0 yr	—	$7M	659,750

Search